首页 | 本学科首页   官方微博 | 高级检索  
检索        

免疫球蛋白轻链淀粉样变性的治疗进展
引用本文:马峰,孙世仁.免疫球蛋白轻链淀粉样变性的治疗进展[J].新医学,2014(1):1-4.
作者姓名:马峰  孙世仁
作者单位:第四军医大学西京医院肾脏内科, 西安710032
摘    要:免疫球蛋白轻链淀粉样变性(AL-淀粉样变性)的特点是骨髓浆细胞产生单克隆免疫球蛋白λ或κ轻链增生,这些不溶性蛋白沉积在组织器官引起组织器官结构损害及功能障碍。传统治疗(马法兰和肾上腺皮质激素)效果差,血液学缓解率较低。近年来自体造血干细胞移植和新的化学治疗方案提高了AL-淀粉样变性治疗的血液学缓解率和延长了生存时间,为该病的治疗带来新希望。该文重点就近年来AL-淀粉样变性的治疗进展作一介绍。

关 键 词:AL-淀粉样变性  传统治疗  自体造血干细胞移植  化学治疗

Progression of treatment on immunoglobulin light chain amyloidosis
MA Feng,SUN Shi-ren.Progression of treatment on immunoglobulin light chain amyloidosis[J].New Chinese Medicine,2014(1):1-4.
Authors:MA Feng  SUN Shi-ren
Institution:( Xifing Hospital of the Fourth Military Medical University Nephrology, Xi'an 710032, China)
Abstract:Immunoglobulin light chain (AL)amyloidosis is characterized by a clonal population of bone marrow plasma cells that produces a monoclonal light chain ofλorκtype. This insoluble protein deposits in tissues and interferes with organ function. Conventional treatment of AL-amyloidosis (melphalan and corti-costeroids) rarely resulted in hematologic complete response. In recent years,autologous stem cell transplanta-tion and some new chemical treatments resulted in higher hematologic response rates and survival ratea when compared with conventional treatment. This article mainly reviewed the progresses of treatments.
Keywords:Immunoglobulin light chain amyloidosis  Conventional treatment  Autologous stem cell transplantation  Chemical treatment
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号